Catalog Number |
PR35607660 |
CAS |
35607-66-0 |
Structure |  |
Description |
Cefoxitin is a semisynthetic cephamycin antibiotic which, in addition to the methoxy group at the 7alpha position, has 2-thienylacetamido and carbamoyloxymethyl side-groups. It is resistant to beta-lactamase. It has a role as an antibacterial drug |
Synonyms |
Mefoxin; CEPHOXITIN; Cefoxitina; Cefoxitine |
IUPAC Name |
(6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
Molecular Weight |
427.5 |
Molecular Formula |
C16H17N3O7S2 |
InChI |
WZOZEZRFJCJXNZ-ZBFHGGJFSA-N |
InChI Key |
InChI=1S/C16H17N3O7S2/c1-25-16(18-10(20)5-9-3-2-4-27-9)13(23)19-11(12(21)22)8(6-26-15(17)24)7-28-14(16)19/h2-4,14H,5-7H2,1H3,(H2,17,24)(H,18,20)(H,21,22)/t14-,16+/m1/s1 |
Associated Therapies |
Antibiotic pre-surgical prophylaxis |
Drug Categories |
Amides; Anti-Bacterial Agents; Anti-Infective Agents; Antibacterials for Systemic Use; Antiinfectives for Systemic Use; beta-Lactams; Cephalosporins; Cephamycins; Heterocyclic Compounds, Fused-Ring; Lactams; Nephrotoxic agents; Second-Generation Cephalosporins; Sulfur Compounds; Thiazines |
Drug Interactions |
Abacavir-Cefoxitin may decrease the excretion rate of Abacavir which could result in a higher serum level. Abciximab-The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefoxitin. Aceclofenac-The risk or severity of nephrotoxicity can be increased when Cefoxitin is combined with Aceclofenac. Acemetacin-The risk or severity of nephrotoxicity can be increased when Cefoxitin is combined with Acemetacin. Acenocoumarol-The risk or severity of bleeding can be increased when Cefoxitin is combined with Acenocoumarol. |
Half-Life |
The half-life after an intravenous dose is 41 to 59 minutes. |
Isomeric SMILES |
CO[C@@]1([C@@H]2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)O)NC(=O)CC3=CC=CS3 |
Type |
Small Molecule |
Therapeutic Category |
Antibacterials |
It should be noted that our service is only used for research, not for clinical use.